ERBB2 and breast cancer: In addition to Mcl-1/Her2-dependent survival pathways, our results indicate the existence of Mcl-1-dependent survival pathways in Her2-positive BC cells, which are independent of the Mcl-1–Her2 axis (Fig. 8).